All ABBV Content

AbbVie (ABBV) AbbVie Showcases Late‑Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE®) in Platinum‑Sensitive Ovarian Cancer (PSOC) at SGO 2026

AbbVie (NYSE: ABBV) FY 2026 Other Release

April 12, 20261 min read

AbbVie (ABBV) BOTOX® Cosmetic (onabotulinumtoxinA) Empowers Women Entrepreneurs Through “The Confidence Collective” for Fourth Year

AbbVie (NYSE: ABBV) FY 2026 Other Release

April 8, 20261 min read

AbbVie (ABBV) Allergan Aesthetics Third State-of-the-Art AMI Center Opens in Austin

AbbVie (NYSE: ABBV) FY 2026 Other Release

April 7, 20261 min read

AbbVie (ABBV) Sec Form 8K

AbbVie (NYSE: ABBV) Sec Form 8K

April 5, 20261 min read

AbbVie (ABBV) Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 31, 20261 min read

AbbVie (ABBV) Q1 2026 Earnings Call

AbbVie (NYSE: ABBV) Q1 2026 Earnings Conference

March 31, 20261 min read

AbbVie (ABBV) Q1 2026 Earnings Announcement

AbbVie (NYSE: ABBV) Q1 2026 Earnings Announcement

March 31, 20261 min read

AbbVie (ABBV) Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 30, 20261 min read

AbbVie (ABBV) AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 27, 20261 min read

AbbVie (ABBV) Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM at AMWC Monaco

AbbVie (NYSE: ABBV) FY 2026 Other Release

March 26, 20261 min read